Haleon (HLN) Invested Capital (2021 - 2026)
Haleon's (HLN) quarterly Invested Capital came in at $1.1 billion in Q4 2025, down 41.31% YoY from $1.9 billion in Q4 2024, and down 41.31% on a QoQ basis from $1.9 billion in Q4 2024.
Haleon (HLN) Invested Capital (2021 - 2026) Analysis & Trends
Haleon (HLN) has 5 years of Invested Capital data on file, last reported at $1.1 billion in Q4 2025.
- Quarterly Invested Capital fell 41.31% year-over-year to $1.1 billion in Q4 2025, while the trailing twelve-month figure through Jun 2026 was $14.0 billion (changed N/A YoY) and the FY2025 annual result came in at $1.1 billion, down 41.5% from the prior year.
- Invested Capital eased to $1.1 billion in Q4 2025, from $1.9 billion in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $11.6 billion in Q4 2022 to a low of $1.1 billion in Q4 2025.
- A 5-year average of $7.6 billion and a median of $10.9 billion in 2024 frame the typical range for Invested Capital.
- Annual changes were most pronounced in 2022 — Invested Capital soared 145.29% — and 2024, when it tumbled 83.35%.
- Tracing HLN's Invested Capital over 5 years: stood at $4.7 billion in 2021, then soared by 145.29% to $11.6 billion in 2022, then dropped by 0.91% to $11.5 billion in 2023, then plunged by 83.35% to $1.9 billion in 2024, then tumbled by 41.31% to $1.1 billion in 2025.
- The last three Invested Capital figures came in at $1.1 billion (Q4 2025), $1.9 billion (Q4 2024), and $10.9 billion (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | 9.90 Bn |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | 4.50 Bn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | 3.74 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 1.74 Bn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 73.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | 630.00 Mn |
| 10 | Alkermes | 8.20 Bn | 7.55 Bn | 397.90 Mn | 26.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.90 Bn |
| Dec 31, 2025 | 1.12 Bn |
| Dec 31, 2024 | 1.91 Bn |
| Jun 30, 2024 | 10.93 Bn |
| Dec 31, 2023 | 11.46 Bn |
| Jun 30, 2023 | 11.50 Bn |
| Dec 31, 2022 | 11.57 Bn |
| Dec 31, 2021 | 4.72 Bn |